Biosynex SA (FRA:0DL)

Biosynex Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.76	4.69	20.17	87.17	132.03	36.84
Short-Term Investments	5	5	6	-	-	-
Cash & Short-Term Investments	9.76	9.69	26.16	87.17	132.03	36.84
Cash Growth	-9.12%	-62.96%	-69.99%	-33.98%	258.43%	1368.38%
Accounts Receivable	8.26	7.1	10.65	14.7	25.27	11.49
Other Receivables	13.31	6.21	5.84	14.09	6.08	5.78
Receivables	21.57	13.31	16.49	28.79	31.35	17.27
Inventory	25.94	32.67	38.21	37.67	31.15	32.55
Prepaid Expenses	2.01	-	-	1.43	1.05	-
Other Current Assets	1.76	4.18	4.83	3.35	2.27	-
Total Current Assets	61.75	64.39	91.35	159.61	198.78	87.53
Property, Plant & Equipment	9.49	11.82	11.94	6.38	3.44	2.36
Long-Term Investments	0.44	0.39	0.47	2.57	3.28	1.98
Goodwill	39.39	64.13	91.54	60.91	46.24	29.27
Other Intangible Assets	5.82	20.71	21.76	25.95	5.89	1.28
Long-Term Deferred Charges	27.58	28.11	16.36	-	-	0.63
Other Long-Term Assets	4.96	5.13	8.3	4.93	11.31	3.02
Total Assets	149.44	194.69	241.73	260.34	268.94	126.07
Accounts Payable	14.01	16.31	15.07	14.99	18.73	19.59
Accrued Expenses	4.91	8.15	6.19	6.62	7.64	6.64
Short-Term Debt	-	0.22	0.24	0.04	0.04	0.05
Current Portion of Long-Term Debt	48.42	46.98	-	49.48	0.15	5.96
Current Portion of Leases	0.45	0.47	-	1.41	-	-
Current Income Taxes Payable	4.71	0.01	0.01	1.73	19.81	13.65
Current Unearned Revenue	0.34	0.23	0.51	0.22	1.94	0.07
Other Current Liabilities	0.07	5.33	9.17	8.36	12.45	3.11
Total Current Liabilities	72.91	84.29	34.67	83.86	61.32	49.08
Long-Term Debt	12.58	14.14	63.88	1.15	34.08	9.75
Long-Term Leases	0.59	0.82	1.84	-	1.04	-
Other Long-Term Liabilities	14.37	14.94	17.02	8.43	4.69	0.95
Total Liabilities	101.39	114.19	117.41	93.45	101.14	59.78
Common Stock	1.88	1.08	1.08	1.03	1.11	0.92
Additional Paid-In Capital	32.78	25.6	25.6	25.6	47.27	27.9
Retained Earnings	-48.58	73.8	55.31	77.08	130.92	31.46
Comprehensive Income & Other	61.98	-19.9	42.49	58.83	-11.5	6.01
Total Common Equity	48.05	80.58	124.48	162.53	167.81	66.29
Minority Interest	-	-0.08	-0.17	4.37	-	-
Shareholders' Equity	48.05	80.5	124.32	166.9	167.81	66.29
Total Liabilities & Equity	149.44	194.69	241.73	260.34	268.94	126.07
Total Debt	62.05	62.63	65.96	52.08	35.31	15.77
Net Cash (Debt)	-52.28	-52.94	-39.8	35.1	96.72	21.07
Net Cash Growth	-	-	-	-63.71%	359.13%	-
Net Cash Per Share	-3.55	-4.92	-3.72	3.41	9.31	2.36
Filing Date Shares Outstanding	18.75	18.75	10.76	10.25	10.32	10.04
Total Common Shares Outstanding	18.75	10.76	10.76	10.25	10.32	9.15
Working Capital	-11.16	-19.9	56.68	75.75	137.45	38.45
Book Value Per Share	2.56	7.49	11.57	15.85	16.26	7.24
Tangible Book Value	2.84	-4.27	11.18	75.67	115.67	35.73
Tangible Book Value Per Share	0.15	-0.40	1.04	7.38	11.21	3.90
Buildings	3.45	3.87	3.13	-	-	-
Machinery	21.93	34.26	31.4	10.58	6.37	3.05
Construction In Progress	-	0	0.02	0.03	-	1.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.